fbpx
hidradenitis suppurativa clinical trial

Hidradenitis Suppurativa – Adolescents and Adults

Adults and adolescents who have a diagnosis of moderate to severe hidradenitis suppurativa (HS) may qualify for this clinical research trial and receive investigational injectable medication or placebo.

  • Age: ≥ 16 years old
  • Diagnosis of HS ≥ 6 months
  • HS lesions in ≥ 2 distinct anatomical areas and total lesion count ≥ 5
  • Inadequate response or intolerance to a 12-week trial of oral antibiotics

Patients will be asked to visit the clinic about 19 times over approximately 52 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.

For further information on the study, please follow the link:

Trial ID: NCT06468228

Accreditations & Memberships

Australasian Hair and Wool Research Society
victoria
international academy cosmetic dermatology
european medecines agency
gpce
deakin university
congress dermatology
bellberry limted
australiasian college dermatologists
australian government national health
australian government ip
australian clinical trials
asdr
albinism fellowship australia
aaaf
ahsf
american dermatological association
british association of dermatology
epworth
international society of dermatology
university of melbourne
Book Appointment
Shop